Gene Transfer to the Tracheobronchial Tree: Implications for Fetal Gene Therapy for Cystic Fibrosis

Seminars in Pediatric Surgery

Volumn 13, Issue 1, 2004, Pages 44-52

  Keswani, Sundeep G ^a   Crombleholme, Timothy M ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; LENTIVIRUS VECTOR; PARVOVIRUS VECTOR; TRANSMEMBRANE CONDUCTANCE REGULATOR; VIRUS VECTOR;

ANIMAL MODEL; CLINICAL TRIAL; CYSTIC FIBROSIS; FETAL GENE THERAPY; FETUS DEVELOPMENT; GENE EXPRESSION; GENE FUNCTION; GENE OVEREXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; GENOTYPE; HERPES SIMPLEX VIRUS; HUMAN; IN VITRO STUDY; LUNG DEVELOPMENT; LUNG TRANSPLANTATION; MUTAGENESIS; NONHUMAN; PHENOTYPE; POSTNATAL CARE; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; REVIEW; SCID MOUSE; TARGET CELL; TRACHEA MUCOSA; TRACHEOBRONCHIAL TREE; TREATMENT FAILURE; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT;

EID: 1242343616     PISSN: 10558586     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sempedsurg.2003.09.007     Document Type: Article

References (71)

1. http://www.cff.org. March, 2003
2. Cystic Fibrosis Foundation: Cystic Fibrosis Foundation Patient Registry Annual Report 2000, Bethesda, MD, Cystic Fibrosis Foundation, 2001
3. Ratjen F, Doring G: Cystic fibrosis. Lancet 361:681-689, 2003
4. Engelhardt JF, Yankaskas JR, Ernst SA, et al: Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nat Genet 2:240-248, 1992
5. Englehardt JF, Zepeda M, Cohn JA, et al: Expression of the cystic fibrosis gene in adult human lung. J Clin Invest 93:737-49, 1994
6. Basbaum CB, Jany B, Finkbeiner WE: The serous cell. Annu Rev Physiol 52:97-113, 1990
7. Davies JC, Geddes GM, Alton EWFW: Gene therapy for cystic fibrosis. J Gen Med 3:409-417, 2001
8. Hyde SC, Gill DR, Higgins CF, et al: Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy. Nature 362:250-255, 1993
9. Grubb BR, Pickles RJ, Ye H, et al: Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature 371:802-806, 1994
10. Zabner J, Ramsay BW, Meeker DP, et al: Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis. J Clin Invest 97:1504-1511, 1996
11. Johnson LG, Olsen JC, Sarkadi B, et al: Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nat Genet 2:21-25, 1992
12. Scaria A, St George JA, Jiang C, et al: Adenovirus-mediated persistent cystic fibrosis transmembrane conductance regulator expression in mouse airway epithelium. J Virol 72:7302-7309, 1998
13. Zabner J, Couture LA, Gregory RJ, et al: Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75:207-216, 1993
14. Crystal RG, McElvaney NG, Rosenfeld MA, et al: Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis, Nat Genet 8:42-51, 1994
15. Boucher RC, Knowles MR, Johnson LG, et al: Gene therapy for cystic fibrosis using E1-deleted adenovirus: A phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill. Hum Gene Ther 5:615-639, 1994
16. Zuckermann JB, Robinson CB, McCoy KS, et al: A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane regulator gene to a lung segment of individuals with cystic fibrosis. Hum Gene Ther 10:2973-2985, 1999
17. Bellon G, Michel-Calemard L, Thouvenot D, et al: Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: A phase I clinical trial. Hum Gene Ther 8:15-25, 1997
18. Harvey B-G, Leopold PL, Hackett NR, et al: Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus. J Clin Invest 104:1245-1255, 1999
19. Flotte TR: Recombinant adeno-associated virus vectors for cystic fibrosis gene therapy. Curr Opin Mol Ther 3:497-502, 2001
20. Beck SE, Jones LA, Chesnut K, et al: Repeated delivery of adeno-associated virus vectors to the rabbit airway. J Virol 73:9446-9455, 1999
21. Flotte TR, Afione SA, Conrad C, et al: Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc Natl Acad Sci 90:10613-10617, 1993
22. Wagner JA, Reynolds T, Moran ML, et al: Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus. Lancet 351:1702-1703, 1998
23. Halbert CL, Rutledge EA, Allen JM, et al: Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes. J Virol 74:1524-1532, 2000
24. Halbert CL, Standaert TA, Aitken ML, et al: Transduction by adeno-associated virus vectors in the rabbit airway: Efficiency, persistence, and readministration. J Virol 71:5932-5941, 1997
25. Walters RW, Grunst T, Bergelson JM, et al: Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia. J Biol Chem 274:10219-10226, 1999
26. Fisher KJ, Jooss K, Alston J, et al: Recombinant adeno-associated virus for muscle-directed gene therapy. Nat Med 3:306-312, 1997
27. Flannery JG, Zolotukhin S, Vaquero MI, et al: Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proc Natl Acad Sci USA 94:6916-6921, 1997
28. Kaplitt MG, Leone P, Samulski RJ, et al: Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 8:148-154, 1994
29. Xiao WD, Berta SC, Lu MM, et al: Adeno-associated virus as a vector for liver-directed gene therapy. J Virol 72:10222-10226, 1998
30. Zabner J, Seiler M, Walters R, et al: Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer. J Virol 74:3852-3858, 2000
31. Duan D, Yue Y, Yan Z, et al: Polarity influences the efficiency of recombinant adeno-associated virus infection in differentiated airway epithelia. Hum Gene Ther 9:2761-2776, 1998
32. Rubenstein RC, McVeigh U, Flotte TR, et al: CFTR gene transduction in neonatal rabbits using an adeno-associated virus vector. Gene Ther 4:384-392, 1997
33. Halbert CL, Alexander IE, Wolgamot GM, et al: Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells, J Virol 69:1473-1479, 1995
34. Teramoto S, Barlett JS, McCarty DXX, et al: Factors influencing adeno-associated virus-mediated gene transfer to human cystic fibrosis airway epithelial cells: Comparison with adenovirus vectors. J Virol 72:8904-8912, 1998
35. Guy J, Qi X, Muzyczka N, et al: Reporter expression persists I year after adeno-associated virus-mediated gene transfer to the optic nerve. Arch Ophthalmol 117:929-937, 1999
36. Gao GP, Alvira MR, Wang L, et al: Novel adenoviral-associated viruses from rhesus monkeys as vectors for human gene therapy, Proc Natl Acad Sci USA 99:11854-11859, 2002
37. Hoggan MD, Blacklow NR, Rowe WP: Studies of small DNA viruses found in various adenovirus preparations: Physical, biological, and immunological characteristics. Proc Natl Acad Sci USA 55:1467-1474, 1966
38. Bantel-Schaal U, zur Hausen H: Characterization of the DNA of a defective human parvovirus isolated from a genital site, Virology 134:52-63, 1984
39. Georg-Fries B, Biederlack S, Wolf J, zur Hausen H: Analysis of proteins, helper dependence, and seroepidemiology of a new human parvovirus. Virology 134:64-71, 1984
40. Rutledge EA, Halbert CL, Russell DW: Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J Virol 72:309-319, 1998
41. Xiao W, Chirmule N, Berta SC, et al: Gene therapy vectors based on adeno-associated virus type 1. J Virol 73:3994-4003, 1999
42. Chirmule N, Propert K, Magosin S, et al: Immune responses to adenovirus and adeno-associated virus in humans. Gene Ther 6:1574-1783, 1999
43. Keswani SG, Katz A, Lim FY, et al: Pseudotyped adeno-associated virus gene transfer in wound healing. Mol Ther 7:s186-s187, 2003 (abstract)
44. Hildinger M, Auricchio A, Gao G, et al: Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer. J Virol 75:6199-6203, 2001
45. Kitson C, Angel B, Judd D, et al: The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium. Gene Ther 6:534-546, 1999
46. Pickles RJ, Fahrner JA, Petrella JM, et al: Retargeting the coxsackievirus and adenovirus receptor to the apical surface of polarized epithelial cells reveals the glycocalyx as a barrier to adenovirus-mediated gene transfer, J Virol 74:6050-6057, 2000
47. Zeiher BG, Eichwald E, Zabner J, et al: A mouse model for the delta F508 allele of cystic fibrosis. J Clin Invest 96:2051-2064, 1995
48. Harris A: Towards an ovine model of cystic fibrosis. Hum Mol Genet 6:2191-2194, 1997
49. Larson JE, Morrow SL, Happel L, et al: Reversal of cystic fibrosis phenotype in mice by gene therapy in utero. Lancet 349:619-620, 1997
50. Sekhon H, Larson J: In utero gene transfer into the pulmonary epithelium. Nat Med 1:1201-1203, 1995
51. Duan D, Sehgal A, Yao J, et al: Lefl transcription factor expression defines airway progenitor cell targets for in utero gene therapy of submucosal gland in cystic fibrosis. Am J Respir Cell Mol Biol 18:750-758, 1998
52. Larson JE, Delcarpio JB, Farberman MM, et al: CFTR modulates lung secretory cell proliferation and differentiation. Am J Physiol Lung Cell Mol Physiol 279:L333-L341, 2000
53. Bouchard S, Mackenzie T, Radu, et al: Prolonged expression of adenovirus and adeno-associated virus following fetal administration in the preimmune period. Mol Ther 3:s393-s394, 2001
54. Lipshutz GS, Mahler WR, Contag CH, et al: Tolerance to transgene-encoded protein after in utero injection of adeno-associated viral vectors. Mol Ther 7:s87, 2003
55. Knight AK, Martin BG, Crombleholme TM: Screening of adenoviral and HSV gene therapy vectors for in utero treatment of cystic fibrosis using fetal tracheal organ culture. Surg Forum 50:509-511, 1999
56. Lim FY, Crombleholme TM. Gene transfer in human fetal tracheas. Philadelphia Association of Surgery Meeting, Philadelphia, PA, 2001
57. Lim FY, Martin BG, Sena-Esteves M, et al: Adeno-associated virus (AAV)-mediated gene transfer in respiratory epithelium and submucosal gland cells in human fetal tracheal organ culture. J Pediatr Surg 37:1051-1057, 2002
58. Knight AK, Martin BG, Crombleholme TM: Fetal tracheal organ culture. Pediatrics 104:784, 1999 (abstract)
59. Lim FY, Kobinger GP, Weiner DJ, et al: Human fetal trachea-SCID mouse xenografts: Efficacy of vesicular stomatitis virus-G pseudotyped lentiviral-mediated gene transfer. J Ped Surg 38:834-839, 2003
60. Lim FY, Kobinger GP, Weiner DJ, et al: Filovirus-pseudotyped lentiviral mediated gene transfer in human fetal trachea xenografts. Mol Ther 5:S36, 2002 (abstract)
61. Peault B, Tirouvanziam R, Sombardier MN, et al: Gene transfer to human fetal pulmonary tissue developed in immunodeficient SCID mice. Hum Gene Ther 5:1131-1137, 1994
62. Thurlbeck WM, Benjamin B, Reid L: Development and distribution of mucous gland in the foetal human trachea. Br J Dis Chest 55:54-64, 1961
63. Goldman MJ, Lee PS, Yang JS, et al: Lentiviral vectors for gene therapy of cystic fibrosis. Hum Gene Ther 8:2261-2268, 1995.
64. MacKenzie TC, Kobinger GP, Kootstra NA, et al: Efficient transduction of liver and muscle after in utero injection of lentiviral vectors with different pseudotypes. Mol Ther 6:349-358, 2002
65. Watson DJ, Kobinger GP, Passini MA, et al: Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins. Mol Ther 5:528-537, 2002
66. Kobinger GP, Weiner DJ, Yu QC, et al: Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo. Nat Biotechnol 19:225-230, 2001
67. Burns JC, Friedmann T, Driever W, et al: Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and non-mammalian cells. Proc Natl Acad Sci 90:8033-8037, 1993
68. Trono D: Lentiviral vectors: Turning a deadly foe into a therapeutic agent. Gene Ther 7:20-23, 2000
69. Johnson RG, Olsen JC, Naldini L, et al: Pseudotyped human lentiviral vector-mediated gene transfer to airway epithelia in vivo. Gene Ther 7:568-574, 2000
70. Plopper GH, Weir AJ, Nishio SJ, et al: Tracheal submucosal gland development in the rhesus monkey, Macaca mulatto: Ultrastructure and histochemistry. Anat Embryol 174:167-178, 1986
71. Pameijer C, Tallapragada S, Levy R, et al: Effect of collagen based vector delivery system on the efficiency of adenoviral mediated gene transfer and wound healing. Surg Forum 51:571-573, 2000